Table 1 Characteristics of patients at commencement of interferon therapy

n

22

Sex, (female/male)

6/16

Age, years (range)

33 (22–50)

Previous treatment with interferon

6 (27.2 %)

Previous treatment with nucleoside analog

1 (1.7 %)

Aspartate aminotransferase, IU/L (range)

58 (28–237)

Alanine aminotransferase, IU/L (range)

111 (41–397)

Bilirubin, mg/dL (range)

0.7 (0.3-1.6)

Albumin, g/dL (range)

3.9 (3.5-4.4)

Platelets, ×10³/μL (range)

196 (106–306)

HBsAg, (IU/ml)

2370 (22.1-75500)

Serum HBV DNA, log copies/mL (range)

7.6 (5.3 to >7.6)

HBeAg, positive/negative

17/5

HBV genotype (A/B/C)

2/2/18